New radiation technique aims to slash gut damage in bladder cancer patients
NCT ID NCT05295992
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new type of daily radiation therapy for muscle-invasive bladder cancer that adapts to changes in the body each day. The goal is to see if this approach lowers the chance of diarrhea and other bowel problems compared to standard radiation. About 110 adults with bladder cancer that hasn't spread widely are taking part. The treatment is designed to be more precise, potentially causing fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Herlev and Gentofte Hospital
Herlev, DK-2730, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New strategy aims to eliminate residual bladder cancer after drug combo
- Keytruda may let some bladder cancer patients avoid bladder removal
- Scientists hunt for clues in bladder Cancer's surrounding tissue
- New Drug-Radiation combo aims to spare bladders in cancer patients
- Bladder cancer drug trial halted early after enrolling just 4 patients
- New Bladder-Sparing combo could change how we treat aggressive bladder cancer